Elicio Therapeutics secures $10M senior secured note from board-affiliated investor

Elicio Therapeutics, Inc.

Issued $10M promissory note to GKCC (controlled by board member); interest rate up to 12.5%.
Warrant to purchase 103,225 shares at $7.75 issued; immediately exercisable, 5-year term.
Proceeds plus current cash expected to fund operations into Q1 2026.
AMPLIFY-7P Phase 2 interim analysis for ELI-002 in PDAC anticipated in Q3 2025.
Note matures June 3, 2028; 24-month interest-only period with lump-sum interest payment.

item 1.01item 2.03item 3.02item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.